Skip to main content

Table 1 Clinical characteristics and biochemical evaluation of control subjects (CG) and of patients with postsurgical hypoparathyroidism (PhPTG)

From: Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density

 

CG (n = 17)

PhPTG (n = 16)

Estimated difference

p-value

[C.I.(95%)]

Age (year)

58.0 ± 6.1

62.3 ± 8.9

−4.31(−9.69;1.06)

P = 0.2

Weight(kg)

71.8 ± 13.7

72.6 ± 10.9

−0,82(−9.63;7.98)

P = 0.9

Height (m)

1.58 ± 6.4

1.54 ± 7.9

4.18(−0.95;9.31)

P = 0.8

BMI (kg/m2)

28.5 ± 5.5

30.3 ± 4.2

−1.84(−5.33;1.65)

P = 0.4

Duration of PhPT

-

15.3 ± 12.4

  

Total calcium (mmol/L)

2.43 ± 0.13*

2.05 ± 0.21

1.45(0.95;1.96)

P <0.0001

Ca X Pi

3.11 ± 0.63

3.21 ± 0.59

−1.15(−6.51;4.21)

P = 0.50

Albumin (g/L)

44.1 ± 2.4*

42.3 ± 1.8

0.18(0.02;0.33)

P < 0.05

Phosphorus (mmol/L)

1.29 ± 0.22*

1.57 ± 0.32

−0.86(−1.46;-0.27)

P < 0.05

Alkaline phosphatase (U/L)

235.4 ± 65.8

198.1 ± 37.14

37.29(−1;75.58)

P = 0.09

Creatinine (μmol/L)

57.96 ± 7.63*

69.39 ± 21.35

−0.30(−0.15;-0.005)

P < 0.05

PTH (ng/L)

42.0 ± 18.7*

5.9 ± 4.6

36.05(26.23;45.88)

P < 0.0001

25-hydroxyvitamin D (nmol/L)

82.0 ± 35.02

100.8 ± 31.47

−18.9(−42.6;4.85)

P = 0.11

IGF-I (μg/L)

68.76 ± 43.55

51.94 ± 19.15

16.83(−7.33;40.98)

P = 0.53